A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology.

The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment in New York City in March and April 2020. 

Venous thromboembolism is a common complication among hospitalized patients, one that leads to longer lengths of stay and costs health systems up to $10 billion annually.

Is it time to start routinely treating COVID-19 patients with anticoagulants?

Vascular Solutions is recalling all Langston Dual Lumen Catheters distributed from July 12, 2019, to March 10, 2020.

E-cigarettes can cause just as much damage to a person’s arteries and blood vessels as traditional cigarettes, according to a new study published in the Journal of the American Heart Association.

Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association.

Hospitalized COVID-19 patients experience a high rate of thromboembolic complications, according to new findings published in Thrombosis Research.

Some middle-aged women may think they have waited too long to reduce their risk of stroke by adopting a healthier lifestyle—that it is too late for such a change to make an impact.

The COVID-19 pandemic is changing patient care at hospitals all over the world, but a group of leading surgeons wants to make sure people aren’t ignoring stroke symptoms due to fears over getting the virus.

Cardiac injury is common among patients hospitalized with COVID-19, according to new research out of Wuhan, China. The study, published in JAMA Cardiology, also found that cardiac injuries were associated with an increased risk of in-hospital mortality.

Endologix, an Irvine, California-based healthcare technology company, has received FDA approval for its new abdominal stent graft solution.